Research: Shire Pharmaceutical

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.

PR Newswire

2009-09-14 20:01
Hampshire SelfStorage and U-Haul Give Customers Peace of Mind

2009-09-14 08:00
Wilshire Enterprises, Inc. Announces Final Results of its Issuer Tender Offer

2009-09-08 16:00
You Shop, We Ship! Midtown's Luxurious Omni Berkshire Place Lightens the Load for Holiday Shoppers With Free Shipping

2009-09-08 08:00
Wilshire Enterprises, Inc. Announces Preliminary Results of its Issuer Tender Offer

2009-09-03 12:00
Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17

2009-09-02 12:03
Verizon Wireless Expands 3G Wireless Network in Newmarket, New Hampshire

2009-09-01 04:00
Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials

2009-08-27 16:00
Berkshire Homestate Goes Live With Phase II of Duck Creek Technologies' Policy Administration Solution and Adds Billing Solution

2009-08-24 08:00
Santaris Pharma A/S Forms Strategic Alliance With Shire plc to Develop RNA-Based Medicines for the Treatment of Rare Genetic Disorders

2009-08-24 08:00
Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A/S on LNA Drug Platform

2009-08-20 16:00
New Hampshire, Massachusetts and Rhode Island Residents Arrested for Promoting and Using Tax Defier Schemes

2009-08-17 12:00
Shire Initiates Two Adult ADHD Outreach Programs

2009-08-11 12:00
Anthem Blue Cross and Blue Shield in New Hampshire, Elliot Hospital Announce Renewed Contract, Quality Initiative

2009-08-10 08:00
Wilshire Enterprises, Inc. Commences Issuer Tender Offer to Purchase up to 4,000,000 Shares of Common Stock

2009-08-06 00:02
AT&T Continues New Hampshire Network Expansion

2009-08-05 08:00
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

2009-08-03 04:00
Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

2009-07-28 08:02
Nottinghamshire Police First Law Enforcement Agency to Deploy ForensicSoft in United Kingdom

2009-07-16 12:00
Anthem Blue Cross and Blue Shield in New Hampshire Gives Boost to Help Small Businesses in the Granite State

2009-07-16 04:00
Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease

2009-07-06 16:00
Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease

2009-06-29 08:00
Kevin Nee Named President of Wilshire Private Markets

2009-06-17 12:03
Newest Verizon Wireless Communications Store In Portsmouth, New Hampshire Offers Hands-On Experience With the Latest in Wireless

2009-06-15 12:02
Verizon Wireless Expands 3G Wireless Network in Dublin, New Hampshire

2009-06-12 12:02
Verizon Wireless Expands 3G Wireless Network in Madison, New Hampshire

2009-06-11 12:02
Verizon Wireless Expands 3G Wireless Network in Gorham, New Hampshire

2009-06-05 12:02
Verizon Wireless Expands 3G Wireless Network in Wolfeboro, New Hampshire

2009-06-04 12:02
Verizon Wireless Expands 3G Wireless Network in Claremont, New Hampshire

2009-06-02 12:02
Verizon Wireless Expands 3G Wireless Network in Winchester, New Hampshire

2009-06-01 12:02
Verizon Wireless Expands 3G Wireless Network in Walpole, New Hampshire

2009-06-01 08:00
Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week

Pharmaceutical Business Review

2009-09-08 20:03
Shire Provides Update On Velaglucerase Alfa
The company to initiate dosing, starting September

2009-09-07 12:03
Shire Receives FDA Approval For Intuniv Extended Release Tablets
For the treatment of attention-deficit/hyperactivity disorder in children and adolescents aged 6 to17 years

2009-09-04 12:04
Shire Gets FDA Approval For INTUNIV
INTUNIV, to treat Attention-Deficit/Hyperactivity Disorder

2009-09-01 12:04
Shire Completes Submission Of NDA For Velaglucerase Alfa
Shire reports positive results for remaining two phase III trials

2009-08-04 12:03
Shire Reports Positive Results From Phase III Studies Of Velaglucerase Alfa
FDA has accepted Shire's treatment protocol for velaglucerase alfa

2009-07-28 12:03
Shire Receives FDA's Complete Response Letter For INTUNIV Extended Release
INTUNIV (guanfacine), for the treatment of ADHD in children and adolescents

2009-07-07 12:03
Shire Files Treatment Protocol For Gaucher Disease
Shire to initially provide velaglucerase alfa free of charge

2009-07-02 16:04
Shire Provides Results For Phase 3b Vyvanse Study
Vyvanse improved the ability to focus and organize, as well as hyperactivity and impulsivity

2009-11-04 08:00
Mixed Finish After Buffett's Big Bet
Two of three major indexes pull into positive territory Tuesday after Berkshire shells out $34B for railroad.

Computer Business Review Online

2010-03-04 16:01
Yorkshire Water builds benefits scheme
?With a little help from some User Group friends

2009-08-20 12:03
Hertfordshire schools benefit from broadband boost
Faster, more reliable access to e-learning tools

2009-06-02 08:03
Capgemini secures Derbyshire IT overhaul deal
Contract worth 5m for SAP tech

2009-06-01 00:03
HP to shed jobs at Scots plant
Plans to close its manufacturing operations in Erskine and Renfrewshire